{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:21Z","timestamp":1787020701350,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13018-017-0585-0","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T08:01:02Z","timestamp":1496908862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Investigation and management of osteoporosis in aged trauma patients: a treatment algorithm adapted to the German guidelines for osteoporosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Carl","family":"Neuerburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Mittlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schmidmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kammerlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"B\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf","family":"Mutschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"issue":"1","key":"585_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-006-0206-y","volume":"18","author":"B Haussler","year":"2007","unstructured":"Haussler B, Gothe H, Gol D, Glaeske G, Pientka L, Felsenberg D. Epidemiology, treatment and costs of osteoporosis in Germany\u2014the BoneEVA Study. Osteoporos Int. 2007;18(1):77\u201384.","journal-title":"Osteoporos Int"},{"issue":"4","key":"585_CR2","first-page":"52","volume":"110","author":"P Hadji","year":"2013","unstructured":"Hadji P, Klein S, Gothe H, H\u00e4ussler B, Kless T, Schmidt T, Steinle T, Verheyen F, Linder R. Epidemiologie der Osteoporose - Bone Evaluation Study: Eine Analyse von Krankenkassen-Routinedaten. Dtsch Arztebl Int. 2013;110(4):52\u20137.","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"585_CR3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.5414\/CP201931","volume":"51","author":"P Hadji","year":"2013","unstructured":"Hadji P, Klein S, Haussler B, Kless T, Linder R, Rowinski-Jablokow M, Verheyen F, Gothe H. The bone evaluation study (BEST): patient care and persistence to treatment of osteoporosis in Germany. Int J Clin Pharmacol Ther. 2013;51(11):868\u201372.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"585_CR4","unstructured":"Dachverband Osteologie. DVO Leitlinie Osteoporose 2014 (Kurzfassung und Langfassung). \nhttp:\/\/www.dv-osteologie.org\/uploads\/Leitlinie2014\/DVO-LeitlinieOsteoporose2014KurzfassungundLangfassungVersion1a12012016.pdf\n\n."},{"issue":"Suppl 2","key":"585_CR5","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1007\/s00198-010-1251-0","volume":"21","author":"C Cooper","year":"2010","unstructured":"Cooper C. Osteoporosis: disease severity and consequent fracture management. Osteoporos Int. 2010;21 Suppl 2:S425\u20139.","journal-title":"Osteoporos Int"},{"issue":"2","key":"585_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00113-013-2500-4","volume":"118","author":"F Haasters","year":"2015","unstructured":"Haasters F, Prall WC, Himmler M, Polzer H, Schieker M, Mutschler W. Prevalence and management of osteoporosis in trauma surgery: implementation of national guidelines during inpatient fracture treatment. Unfallchirurg. 2015;118(2):138\u201345.","journal-title":"Unfallchirurg"},{"key":"585_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2474-12-187","volume":"12","author":"L Kolios","year":"2011","unstructured":"Kolios L, Takur C, Moghaddam A, Hitzler M, Schmidt-Gayk H, Suda AJ, Honer B, Grutzner PA, Wolfl C. Anamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density). BMC Musculoskelet Disord. 2011;12:187.","journal-title":"BMC Musculoskelet Disord"},{"key":"585_CR8","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012;344, e3427.","journal-title":"BMJ"},{"issue":"4","key":"585_CR9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00198-012-2115-6","volume":"24","author":"O Strom","year":"2013","unstructured":"Strom O, Jonsson B, Kanis JA. Intervention thresholds for denosumab in the UK using a FRAX(R)-based cost-effectiveness analysis. Osteoporos Int. 2013;24(4):1491\u2013502.","journal-title":"Osteoporos Int"},{"issue":"5","key":"585_CR10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00198-004-1718-y","volume":"16","author":"SA Jamal","year":"2005","unstructured":"Jamal SA, Leiter RE, Bayoumi AM, Bauer DC, Cummings SR. Clinical utility of laboratory testing in women with osteoporosis. Osteoporos Int. 2005;16(5):534\u201340.","journal-title":"Osteoporos Int"},{"issue":"17","key":"585_CR11","first-page":"1120","volume":"100","author":"RE Willburger","year":"2003","unstructured":"Willburger RE, Knorth H. Osteoporose der Wirbels\u00e4ule: Therapieoption und Pr\u00e4ventionsstrategien. Dtsch Arztebl Int. 2003;100(17):1120.","journal-title":"Dtsch Arztebl Int"},{"issue":"1\u20132","key":"585_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1\u20132):136.","journal-title":"Arch Osteoporos"},{"issue":"2","key":"585_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375\u201382.","journal-title":"Bone"},{"issue":"1","key":"585_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bone.2013.05.022","volume":"56","author":"A Maghraoui El","year":"2013","unstructured":"El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Dehhaoui M, Ghozlani I. Vertebral fractures and abdominal aortic calcification in postmenopausal women. A cohort study. Bone. 2013;56(1):213\u20139.","journal-title":"Bone"},{"issue":"4","key":"585_CR15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00198-012-2048-0","volume":"24","author":"M Tenne","year":"2013","unstructured":"Tenne M, McGuigan F, Besjakov J, Gerdhem P, Akesson K. Degenerative changes at the lumbar spine\u2014implications for bone mineral density measurement in elderly women. Osteoporos Int. 2013;24(4):1419\u201328.","journal-title":"Osteoporos Int"},{"issue":"9","key":"585_CR16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137\u201348.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"585_CR17","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00198-016-3544-4","volume":"27","author":"M Jurisson","year":"2016","unstructured":"Jurisson M, Pisarev H, Kanis J, Borgstrom F, Svedbom A, Kallikorm R, Lember M, Uuskula A. Quality of life, resource use, and costs related to hip fracture in Estonia. Osteoporos Int. 2016;27(8):2555\u201366.","journal-title":"Osteoporos Int"},{"issue":"18","key":"585_CR18","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799\u2013809.","journal-title":"N Engl J Med"},{"issue":"7","key":"585_CR19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00113-007-1258-y","volume":"110","author":"U Frerichmann","year":"2007","unstructured":"Frerichmann U, Raschke MJ, Stockle U, Wohrmann S, Lohmann R. Proximal femoral fractures in the elderly. Data from health insurance providers on more than 23 million insured persons\u2014part 2. Unfallchirurg. 2007;110(7):610\u20136.","journal-title":"Unfallchirurg"},{"issue":"5","key":"585_CR20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00113-005-0927-y","volume":"108","author":"T Vogel","year":"2005","unstructured":"Vogel T, Dobler T, Bitterling H, Biberthaler P, Kanz KG, Pfeifer KJ, Bartl R, Mutschler W. Osteoporosis in traumatology. Prevalence and management. Unfallchirurg. 2005;108(5):356\u201364.","journal-title":"Unfallchirurg"},{"issue":"2","key":"585_CR21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10039-014-2100-8","volume":"16","author":"M F\u00f6rtsch","year":"2014","unstructured":"F\u00f6rtsch M, Schmidt T, Feldmann C, Maurer T. DVO-Leitlinie (DVO: Dachverband Osteologie) in der osteologischen Schwerpunktpraxis. Trauma Berufskrankh. 2014;16(2):110\u201321.","journal-title":"Trauma Berufskrankh"},{"issue":"9","key":"585_CR22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00198-009-1102-z","volume":"21","author":"LA Ahmed","year":"2010","unstructured":"Ahmed LA, Emaus N, Berntsen GK, Bjornerem A, Fonnebo V, Jorgensen L, Schirmer H, Stormer J, Joakimsen RM. Bone loss and the risk of non-vertebral fractures in women and men: the Tromso study. Osteoporos Int. 2010;21(9):1503\u201311.","journal-title":"Osteoporos Int"},{"issue":"5","key":"585_CR23","first-page":"1455","volume":"25","author":"E Kanterewicz","year":"2014","unstructured":"Kanterewicz E, Puigoriol E, Garcia-Barrionuevo J, del Rio L, Casellas M, Peris P. Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study. Osteoporos Int. 2014;25(5):1455\u201364.","journal-title":"Osteoporos Int"},{"issue":"3","key":"585_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jbmr.1476","volume":"27","author":"S Gehlbach","year":"2012","unstructured":"Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, Diez-Perez A, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012;27(3):645\u201353.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"585_CR25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1302\/0301-620X.94B7.29079","volume":"94","author":"TY Kim","year":"2012","unstructured":"Kim TY, Ha YC, Kang BJ, Lee YK, Koo KH. Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint SurgBr. 2012;94(7):956\u201360.","journal-title":"J Bone Joint SurgBr"},{"issue":"4","key":"585_CR26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","volume":"43","author":"MM McDonald","year":"2008","unstructured":"McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone. 2008;43(4):653\u201362.","journal-title":"Bone"},{"issue":"4","key":"585_CR27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/(SICI)1097-4636(19980915)41:4<574::AID-JBM9>3.0.CO;2-9","volume":"41","author":"WJ Dhert","year":"1998","unstructured":"Dhert WJ, Thomsen P, Blomgren AK, Esposito M, Ericson LE, Verbout AJ. Integration of press-fit implants in cortical bone: a study on interface kinetics. J Biomed Mater Res. 1998;41(4):574\u201383.","journal-title":"J Biomed Mater Res"},{"issue":"7","key":"585_CR28","first-page":"593","volume":"89","author":"A Nehme","year":"2003","unstructured":"Nehme A, Maalouf G, Tricoire JL, Giordano G, Chiron P, Puget J. Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study. Rev Chir Orthop Reparatrice Appar Mot. 2003;89(7):593\u20138.","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"issue":"2","key":"585_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/17453671003761946","volume":"81","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 2010;81(2):234\u20136.","journal-title":"Acta Orthop"},{"issue":"19","key":"585_CR30","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, et al. Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434\u201341.","journal-title":"N Engl J Med"},{"issue":"3","key":"585_CR31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1359\/jbmr.090826","volume":"25","author":"JA Cauley","year":"2010","unstructured":"Cauley JA, Parimi N, Ensrud KE, Bauer DC, Cawthon PM, Cummings SR, Hoffman AR, Shikany JM, Barrett-Connor E, Orwoll E, et al. Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res. 2010;25(3):545\u201353.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"585_CR32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bone.2006.09.026","volume":"40","author":"P Garnero","year":"2007","unstructured":"Garnero P, Munoz F, Sornay-Rendu E, Delmas PD. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone. 2007;40(3):716\u201322.","journal-title":"Bone"},{"key":"585_CR33","first-page":"500","volume":"810","author":"HA Bischoff-Ferrari","year":"2014","unstructured":"Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol. 2014;810:500\u201325.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"585_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","volume":"367","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40\u20139.","journal-title":"N Engl J Med"},{"issue":"48","key":"585_CR35","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1055\/s-0031-1297267","volume":"136","author":"M Drey","year":"2011","unstructured":"Drey M, Bollheimer C. Vitamin D supplementation in the elderly. Dtsch Med Wochenschr. 2011;136(48):2463\u20135.","journal-title":"Dtsch Med Wochenschr"},{"issue":"7","key":"585_CR36","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8671","key":"585_CR37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0140-6736(89)91124-0","volume":"2","author":"MF Holick","year":"1989","unstructured":"Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet. 1989;2(8671):1104\u20135.","journal-title":"Lancet"},{"issue":"4","key":"585_CR38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477\u2013501.","journal-title":"Endocr Rev"},{"issue":"8","key":"585_CR39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00198-008-0814-9","volume":"20","author":"CJ Bacon","year":"2009","unstructured":"Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int. 2009;20(8):1407\u201315.","journal-title":"Osteoporos Int"},{"issue":"18","key":"585_CR40","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","volume":"303","author":"KM Sanders","year":"2010","unstructured":"Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. Jama. 2010;303(18):1815\u201322.","journal-title":"Jama"},{"issue":"11","key":"585_CR41","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/jbmr.2279","volume":"29","author":"JR Lewis","year":"2014","unstructured":"Lewis JR, Barre D, Zhu K, Ivey KL, Lim EM, Hughes J, Prince RL. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study. J Bone Miner Res. 2014;29(11):2489\u201397.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"585_CR42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2013.09.014","volume":"57","author":"M Maggio","year":"2013","unstructured":"Maggio M, Lauretani F, Ceda GP, De Vita F, Bondi G, Corsonello A, Cattabiani C, Lattanzio F, Ruggiero C, Nouvenne A, et al. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Bone. 2013;57(2):437\u201342.","journal-title":"Bone"},{"issue":"6","key":"585_CR43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00223-014-9855-6","volume":"94","author":"J Ding","year":"2014","unstructured":"Ding J, Heller DA, Ahern FM, Brown TV. The relationship between proton pump inhibitor adherence and fracture risk in the elderly. Calcif Tissue Int. 2014;94(6):597\u2013607.","journal-title":"Calcif Tissue Int"},{"key":"585_CR44","unstructured":"Leitlinienreport zur S3-Leitlinie: Bisphosphonat- assoziierte Kiefernekrose (BP-ONJ) und andere Medikamenten-assoziierte Kiefernekrosen. AWMF-Register-Nr 007-091 2012."},{"issue":"3","key":"585_CR45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","volume":"58","author":"BJ Gertz","year":"1995","unstructured":"Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58(3):288\u201398.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"585_CR46","first-page":"998","volume":"171","author":"B Abrahamsen","year":"2011","unstructured":"Abrahamsen B, Eiken P, Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med. 2011;171(11):998\u20131004.","journal-title":"Arch Intern Med"},{"issue":"1","key":"585_CR47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00198-011-1574-5","volume":"23","author":"C Roux","year":"2012","unstructured":"Roux C, Goldstein JL, Zhou X, Klemes A, Lindsay R. Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors. Osteoporos Int. 2012;23(1):277\u201384.","journal-title":"Osteoporos Int"},{"issue":"5","key":"585_CR48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5414\/CP201632","volume":"50","author":"V Ziller","year":"2012","unstructured":"Ziller V, Kostev K, Kyvernitakis I, Boeckhoff J, Hadji P. Persistence and compliance of medications used in the treatment of osteoporosis\u2014analysis using a large scale, representative, longitudinal German database. Int J Clin Pharmacol Ther. 2012;50(5):315\u201322.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"7","key":"585_CR49","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1359\/jbmr.090209","volume":"24","author":"EF Eriksen","year":"2009","unstructured":"Eriksen EF, Lyles KW, Colon-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, et al. Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res. 2009;24(7):1308\u201313.","journal-title":"J Bone Miner Res"},{"key":"585_CR50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJWH.S7322","volume":"2","author":"JA Sunyecz","year":"2010","unstructured":"Sunyecz JA. Zoledronic acid infusion for prevention and treatment of osteoporosis. Int J Womens Health. 2010;2:353\u201360.","journal-title":"Int J Womens Health"},{"key":"585_CR51","doi-asserted-by":"crossref","unstructured":"Schray D, Stumpf U, Kammerlander C, B\u00f6cker W, Neuerburg C. Diagnosis and therapy of osteoporosis in geriatric trauma patients: an update. Inn Sur Sci. 2016;1(2):65-71.","DOI":"10.1515\/iss-2016-0028"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-017-0585-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T08:01:14Z","timestamp":1496908874000},"score":1,"resource":{"primary":{"URL":"http:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-017-0585-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1186\/s13018-017-0585-0","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]},"article-number":"86"}}